Dermacinrx Zinc Oxide Skin Healing Paste
NDC Package 59088-563-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Dermacinrx Zinc Oxide Skin Healing (zinc oxide) pastes is a medication used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). This formulation utilizes a paste delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-563 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
59088-563-01
Package Description
4 g in 1 PACKET
Product Code
11-Digit Billing Format
59088056301
RxNorm Crosswalk
  • RxCUI: 308714 - clotrimazole 1 % / betamethasone 0.05 % Topical Cream
  • RxCUI: 308714 - betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream
  • RxCUI: 308714 - betamethasone 0.05 % / clotrimazole 1 % Topical Cream
  • RxCUI: 308714 - betamethasone 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) / clotrimazole 10 MG/ML Topical Cream
  • RxCUI: 416684 - zinc oxide 20 % Topical Paste

Clinical Specifications

Proprietary Name
Dermacinrx Zinc Oxide Skin Healing
Non-Proprietary Name
Zinc Oxide
Substance Name
Zinc Oxide
Dosage Form
Paste - A semisolid3 dosage form, containing a large proportion (20 – 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-03-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-563-01 identifies a specific commercial package of 4 g in 1 packet of Dermacinrx Zinc Oxide Skin Healing, a human over the counter drug labeled by Puretek Corporation. This paste is formulated for topical use and contains zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on August 03, 2016. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088056301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-563-01
11-Digit CMS (5-4-2)
59088-0563-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.